Cellcept 250 mg Tablet contains Mycophenolate mofetil, an immunosuppressant used primarily to prevent organ rejection in transplant patients. It lowers the possibility of the body attacking the transplanted organ by inhibiting the immune system's reaction.
As directed by your physician, take one or two hours before or after a meal, empty-handed, using a 250 mg tablet. Even if you feel fine, keep taking it as prescribed to avoid transplant rejection.
Cellcept 250 mg Tablet contains Mycophenolate mofetil, an immunosuppressant used primarily to prevent organ rejection in transplant patients. It lowers the possibility of the body attacking the transplanted organ by inhibiting the immune system's reaction.
Brand Name: Cellcept
Composition: Mycophenolate mofetil
Mechanism of Action:
A prodrug called mycophenolate mofetil is transformed by the body into mycophenolic acid (MPA). The enzyme inosine monophosphate dehydrogenase (IMPDH), which is required for T- and B-lymphocyte proliferation, is inhibited by MPA. It reduces the immunological response that can target transplanted organs by suppressing these cells.
Uses:
Organ Transplantation: To prevent transplant rejection of the kidney, heart, or liver; frequently used in combination with other immunosuppressants such as corticosteroids and cyclosporine.
Autoimmune Diseases
Dosage and Administration:
The exact dosage varies depending on the type of organ transplant and the individual patient’s condition.
Side Effects:
· Diarrhea
· Nausea
· Vomiting
· Abdominal pain
· Leukopenia (low white blood cell count)
· Anemia
· Increased risk of bacterial infections
· Increased risk of viral infections
· Increased risk of fungal infections
· Headache
· Dizziness
· Fatigue
Safety Advise:
Kidney
Patients with a history of renal impairment should use Cellcept with caution since it may cause other kidney related problems. Kindly speak with your healthcare provider.
Liver
Patients with a history of liver disease should use Cellcept with caution since it may cause other liver related problems. Kindly speak with your healthcare provider.
Pregnancy
Pregnant women should not take Cellcept 250mg Tablets as they may harm the fetus. Kindly speak with your healthcare provider.
Breast Feeding
It's unknown if the 250 mg Cellcept tablet affects your breast milk or if it gets into your breast milk. If you take this medication, ask your doctor how to feed your child the healthiest way possible.
Alcohol
It is advised that you stop drinking while using Cellcept 250 Tablet in order to prevent unwanted side effects. Consuming alcohol in addition to Cellcept 250 Tablet may make you feel more sleepy. Kindly speak with your healthcare provider.
Driving
Since Cellcept 250 Tablet may make you drowsy and faint, avoid driving or operating heavy machinery while using it. Kindly speak with your healthcare provider.
How to use this Medication?
Before beginning to take mycophenolate, as well as with each refill, read the Medication Guide that your pharmacist has provided. Ask your pharmacist or physician any queries you may have.
In general, take this medication by mouth twice a day on an empty stomach, one hour before or two hours after meals, as prescribed by your physician.
Completely swallow the medication. Never chew or crush. Don't open the capsules if you're taking them before swallowing.
Your medical condition and response to treatment will determine the dosage. Moreover, body size influences the dosage for children.
To reap the greatest benefits from this drug, take it on a daily basis. Take it daily at the same times to aid in memory.
References:
1. Masri MA, Rizk S, Attia ML, Barbouch H, Rost M. Bioavailability of a new generic formulation of mycophenolate mofetil MMF 500 versus CellCept in healthy adult volunteers. InTransplantation proceedings 2007 May 1 (Vol. 39, No. 4, pp. 1233-1236). Elsevier.
2. Behrend M. Mycophenolate mofetil (Cellcept). Expert Opinion on Investigational Drugs. 1998 Sep 1;7(9):1509-19.
3. Majithia V, Harisdangkul V. Mycophenolate mofetil (CellCept): an alternative therapy for autoimmune inflammatory myopathy. Rheumatology. 2005 Mar 1;44(3):386-9.
4. Allison AC, Eugui EM. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology. 2000 May 1;47(2-3):85-118.
5. Bullingham RE, Nicholls AJ, Kamm BR. Clinical pharmacokinetics of mycophenolate mofetil. Clinical pharmacokinetics. 1998 Jun;34(6):429-55.
Disclaimer:
The main goal of Apothecare Wellness is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Wellness, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.
Marketer details
Name: Roche Products India Pvt Ltd
Address: 1503, 15th Floor, ‘The Capital’, Plot no. C-70, Behind ICICI Bank, BKC, Bandra (E) , Mumbai 400051
Country of origin: India
We deliver within Bangalore city limits in 24 hours for orders above ₹10,000, with exceptions based on location, while other deliveries rely on trusted courier partners and their timelines.
We provide only authentic, verified medicines sourced from manufacturers or authorized distributors, ensuring proper cold chain storage throughout delivery.
We are available around the clock to assist you.
Shop with confidence, knowing your data is safe with us.